Pharmacists oppose reclassification of pseudoephedrine Products into ethical
Published: 2007-05-10 06:59:00
Updated: 2007-05-10 06:59:00
A senior official in the Korean Pharmaceutical Association said on May 7 that it is not desirable to reclassify OTC decongestants containing pseudoephedrine into prescription drugs, expressing KPA reluctance to accept a proposal from the Korean Medical Association.
The KPA director Ha Young-hw...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
